The N-end rule pathway is one ubiquitin (Ub) proteolytic pathway that relates the in vivo half-life of a protein to the identity of its N terminal residue. Conjugation of arginine (Arg) from Arg-tRNA(Arg) to N-terminal aspartate (Asp), glutamate (Glu), or cysteine (Cys) is part of this proteolytic pathway in that it leads to ubiquitylation of the resulting, Arg-conjugated proteins. We previously observed that ATE1-/- embryos die due to various cardiovascular defects. However, the exact nature of the cardiovascular defects and the underlying molecular mechanisms are unknown. The overall goal of this project is to determine the physiological role of ATE1-dependent arginylation in the myocardial growth and to gain insights into the cardiovascular pathways/molecules in which the ATE1-dependent proteolytic pathway participates. Functional proteomic approach to identify the substrates of the N-end rule pathway and subsequent preliminary characterization of the selected candidate substrates led to the hypothesis that RGS4, RGS5, and RGS16 are ATE1 substrates that may underlie the ATE1-dependent cardiovascular system. RGS proteins are GTPase-activating proteins (GAP) for G(alpha) subunits and negatively regulate the G protein- coupled receptor (GPCR) signaling. RGS4, RGS5, and/or RGS16 have been implicated as important negative regulators of the Gq/Gi-activated signaling for myocardial growth and vascular maturation/integrity. We then asked the mechanism by which these RGS proteins are ubiquitylated for proteolysis by ubiquitin ligases (E3s). Using an affinity-based proteomic approach, we identified a novel protein family, named UBR1-UBR7, that potentially acts for ubiquitylation of RGS4, RGS5, and RGS16. Our overall hypothesis is that the cellular concentrations of RGS4, RGS5, and RGS16, and thus their functions as regulators of the cardiovascular G protein pathways, are regulated through the MetAPs-O2-ATE1-UBR proteolytic cascade. To address this hypothesis and related issues, we propose the following Aims.
Aim 1 : To test whether ATE1 has an in vivo role in intrinsic myocardial growth.
Aim 2 : To determine the role of ATE 1-dependent arginylation for turnover of RGS4, RGS5, and RGS16.
Aim 3 : To elucidate the molecular mechanism by which RGS4, RGS5, and RGS16 are ubiquitylated for proteolysis.
Aim 4 : To examine the physiological consequences of ATE1 knockout on the G protein pathways.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL083365-05
Application #
7873043
Study Section
Cardiovascular Differentiation and Development Study Section (CDD)
Program Officer
Liang, Isabella Y
Project Start
2006-07-15
Project End
2012-03-31
Budget Start
2010-06-01
Budget End
2012-03-31
Support Year
5
Fiscal Year
2010
Total Cost
$350,447
Indirect Cost
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Cha-Molstad, Hyunjoo; Yu, Ji Eun; Feng, Zhiwei et al. (2017) p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis. Nat Commun 8:102
Sun, Jingjing; Liu, Yanhua; Chen, Yichao et al. (2017) Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy. J Control Release 258:43-55
Zhao, Min; Huang, Yixian; Chen, Yichao et al. (2016) PEG-Fmoc-Ibuprofen Conjugate as a Dual Functional Nanomicellar Carrier for Paclitaxel. Bioconjug Chem 27:2198-205
Lee, Dae-Hee; Sung, Ki Sa; Bartlett, David L et al. (2015) HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells. Cell Signal 27:293-305
Ciechanover, Aaron; Kwon, Yong Tae (2015) Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med 47:e147
Cha-Molstad, Hyunjoo; Sung, Ki Sa; Hwang, Joonsung et al. (2015) Amino-terminal arginylation targets endoplasmic reticulum chaperone BiP for autophagy through p62 binding. Nat Cell Biol 17:917-29
Cha-Molstad, Hyunjoo; Kwon, Yong Tae; Kim, Bo Yeon (2015) Amino-terminal arginylation as a degradation signal for selective autophagy. BMB Rep 48:487-8
Zhang, Peng; Huang, Yixian; Kwon, Yong Tae et al. (2015) PEGylated Fmoc-Amino Acid Conjugates as Effective Nanocarriers for Improved Drug Delivery. Mol Pharm 12:1680-90
Yoo, Young Dong; Kwon, Yong Tae (2015) Molecular mechanisms controlling asymmetric and symmetric self-renewal of cancer stem cells. J Anal Sci Technol 6:28
Zhang, Peng; Li, Jiang; Ghazwani, Mohammed et al. (2015) Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy. Biomaterials 67:104-14

Showing the most recent 10 out of 35 publications